Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-7250 multiple-dose study in type 2 diabetes mellitus
jRCT2080221918Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of DS-7250 in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Safety of multiple oral doses of DS-7250, Pharmacokinetics of DS-7250 and 1 more.
02
Drugs
DS-7250
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221918.